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Gene-gene interactions have long been recognized to be funda-
mentally important to understand genetic causes of complex dis-
ease traits. At present, identifying gene-gene interactions from
genome-wide case-control studies is computationally and method-
ologically challenging. In this paper, we introduce a simple but
powerful method, named ‘BOolean Operation based Screening
and Testing’(BOOST). To discover unknown gene-gene interac-
tions that underlie complex diseases, BOOST allows examining
all pairwise interactions in genome-wide case-control studies in a
remarkably fast manner. We have carried out interaction anal-
yses on seven data sets from the Wellcome Trust Case Control
Consortium (WTCCC). Each analysis took less than 60 hours on
a standard 3.0 GHz desktop with 4G memory running Windows
XP system. The interaction patterns identified from the type 1 di-
abetes data set display significant difference from those identified
from the rheumatoid arthritis data set, while both data sets share
a very similar hit region in the WTCCC report. BOOST has also
identified many undiscovered interactions between genes in the
major histocompatibility complex (MHC) region in the type 1 di-
abetes data set. In the coming era of large-scale interaction map-
ping in genome-wide case-control studies, our method can serve
as a computationally and statistically useful tool.
Genome-wide case-control studies use high-throughput genotyping
technologies to assay hundreds of thousands of single-nucleotide
polymorphisms (SNPs) and relate them to clinical conditions or mea-
surable traits. To understand underlying causes of complex disease
traits, it is often necessary to consider joint genetic effects (Epistasis)
across the whole genome. The concept of epistasis [2] was introduced
around 100 years ago. It is generally defined as interactions among
different genes. The existence of epistasis has been widely accepted
as an important contributor to genetic variation in complex diseases
such as asthma, cancer, diabetes, hypertension, and obesity [5]. As a
matter of fact, most researchers believe that it is critical to model com-
plex interactions to elucidate the joint genetic effects causing complex
diseases. They have demonstrated the presence of gene-gene interac-
tions in complex diseases, such as breast cancer [14] and coronary
heart disease [13].
The problem of detecting gene-gene interactions in genome-wide
case-control studies has attracted extensive research interest. The dif-
ficulty of this problem is the heavy computational burden. For ex-
ample, in order to detect pairwise interactions from 500, 000 SNPs
genotyped in thousands of samples, we need 1.25 × 1011 statistical
tests in total. A recent review [5] presented a detailed analysis on
many popular methods, including PLINK [8], MDR [14], Tuning Re-
liefF [12], Random Jungle1(i.e., Random Forest [3]) and BEAM [17].
Among them, PLINK was recommended as the most computation-
ally feasible method that is able to detect gene-gene interactions in
∗These authors contributed equally to this work.
†corresponding author.
1http://randomjungle.com/
genome-wide data 2 [5]. PLINK finished pairwise interaction exam-
ination of 89,294 SNPs selected from the WTCCC Crohn’s disease
data set in 14 days.
Here we propose a new method, named ‘BOolean Operation based
Screening and Testing’ (BOOST), to analyze all pairwise interactions
in genome-wide SNP data. In our method, we use a boolean repre-
sentation of genotype data which is designed to be CPU efficient for
multi-locus analysis. Based on this data representation, we design
a two-stage (screening and testing) search method. In the screening
stage, we use a non-iterative method to approximate the likelihood ra-
tio statistic in evaluating all pairs of SNPs and select those passing a
specified threshold. Most non-significant interactions will be filtered
out and the survival of significant interactions is guaranteed. In the
testing stage, we employ the typical likelihood ratio test to measure
the interaction effects of selected SNP pairs.
Disease BD CAD CD HT RA T1D T2D
C1 10 16 8 7 350 4499 18
C1 & C2 0 0 1 0 0 789 0
C1 & C2 & C3 0 0 1 0 0 91 0
Table 1: The number of interactions identified from seven dis-
eases data set under different constraints. C1 – significant thresh-
old constraint: The significance threshold is 0.05 for the Bonferroni-
corrected interaction P -value; C2 – distance constraint: The physical
distance between two interacting SNPs is at least 1Mb. This constraint
is used to avoid interactions that might be attributed to the linkage dis-
equilibrium (LD) effects [5]; C3 – main effect constraint: The single-
locus P -value should not be less than 10−6. This constraint is used
to see whether there exist strong interactions without significant main
effects because those SNPs with P ≥ 10−6 are usually filtered out in
the typical single-locus scan.
Results
We have applied BOOST to analyze data (14,000 cases in total and
3,000 shared controls) from the Wellcome Trust Case Control Con-
sortium (WTCCC) on seven common human diseases: bipolar dis-
order (BD), coronary artery disease (CAD), Crohn’s disease (CD),
hypertension (HT), rheumatoid arthritis (RA), type 1 diabetes (T1D)
and type 2 diabetes (T2D). The analysis of each disease data set with
control samples took less than 60 hours (around 2.5 days) to com-
pletely evaluate all pairs of roughly 360, 000 SNPs 3 on a standard
3.0 GHz desktop with 4G memory running Windows XP system. The
results under different constraints are reported in Table 1. For T1D,
2Marchini et al. [10] demonstrated that it is feasible to test association allowing for
interactions in genome-wide scale. Beside that, Random Jungle can handle genome-wide
data efficiently. However, they aim at testing associations allowing for interactions, which
is easier than testing interactions. Please check the supplementary document and [5]
for detailed explanations of ‘test of association allowing for interactions’ and ‘test of
interactions’.
3500, 000 SNPs are genotyped in 5, 000 samples, about 360, 000 SNPs can pass
the quality control, see the supplementary for details.
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we discovered many gene-gene interactions in the MHC region (see
detailed descriptions in the following section). For other six diseases,
however, we did not find nontrivial interactions (except one interact-
ing SNP pair in CD).
T1D & RA. The MHC region in chromosome 6 has long been inves-
tigated as the most variable region in the human genome with respect
to infection, inflammation, autoimmunity and transplant medicine [9].
The recent study conducted by WTCCC [15] has shown that both
T1D and RA are strongly associated with the MHC region via single-
locus association mapping. The top-left panel of Figure 1 shows that
the single-locus association map does not reveal much difference be-
tween T1D and RA. In our study, BOOST reports 4499 interactions
in the T1D data set (see Table 1), in which 4489 interactions (99.8%)
are in the MHC region. As comparison, BOOST reports 350 inter-
actions in the RA data set, in which 280 interactions (80.0%) are in
the MHC region. Our genome-wide interaction map provides the ev-
idence that the MHC region is associated with these two diseases in
different ways. The bottom panel of Figure 1 gives detailed interac-
tion maps in the MHC region for T1D and RA data. The LD map 4
of MHC region is provided in the top-right panel of Figure 1. These
interaction maps, different from the LD map, reveal a distinct pattern
difference between T1D and RA. Specifically, there are three sub-
regions in the MHC region, namely, the MHC class I region (29.8Mb -
31.6Mb), the MHC class III region (31.6Mb - 32.3Mb) and the MHC
class II region (32.3Mb - 33.4Mb). A closer inspection of the T1D
interaction map indicates that strong interaction effects widely exist
between genes within and cross three classes, while most significant
interactions in RA only involve loci closely placed in the MHC class
II region. The contrast of the interaction patterns between T1D and
RA may explain their different aetiologies, which are not revealed by
single-locus association mapping.
Interactions without significant main effects detected in T1D. The
MHC region is a highly polymorphic region with a high gene density.
Although previous reports [7, 15] using the single-locus scan have
identified strong associations between MHC genes (such as HLA-
DQB1 and HLA-DRB1) and T1D, it is still unclear which and how
many loci within the MHC region determine T1D susceptibility. In-
teractions without significant main effects can provide additional in-
formation to help pinpoint disease-associated loci because SNPs in-
volved in those interactions are usually filtered out in the single-locus
scan. Among the selected 789 interacting pairs in T1D, 91 pairs have
non-significant loci under the single-locus scan (all of them are listed
in the supplementary). A careful inspection of these 91 interactions
has identified two interesting interaction patterns between the MHC
Class I and Class II. Figure 2 presents one interaction pattern between
the region 31350k-31390k and the region 32810k-32860k in chromo-
some 6. Another pattern between the region 31350k-31390k and the
region 32930k - 32960k in chromosome 6 is provided in the supple-
mentary. The interactions between two regions in Figure 2 are listed
in Table 2. All SNPs in these interactions display weak main effects
while their joint effects are statistically significant. As Nejentsev et
al. [7] argued that both the MHC class I and II genes should be con-
sidered to better understand type 1 diabetes susceptibility, our results
further provide the evidence that the interaction effects between these
two classes may contribute to the aetiology of type 1 diabetes.
COMPUTATION TIME
From a practical point of view, a key issue of detecting gene-gene in-
teractions in genome-wide case-control studies is the computational
efficiency [5]. Cordell [5] reported that PLINK took about 14 days
to test pairwise interactions of the selected 89,294 SNPs on a sin-
gle node of a computer cluster. A rough estimation implies that it
would take approximately 228 days5 to test all pairwise interactions
of 360, 000 SNPs. Random Jungle took about 5 hours to handle the
4We calculate composite LD using the method by Zaykin et al. [16].
5Given the number of samples, the running time of PLINK is proportional to the
square of the number of SNPs. Therefore, the rough estimation is calculated by
14 × (360, 000/89, 294)2 ≈ 228.
SNP 1 SNP 2 Interaction
Single-locus Single-locusSNP
P -value SNP P -value BOOST P -value
rs2524057 4.807 × 10−1 rs9276448 8.878 × 10−3 5.362 × 10−14
rs2524057 4.807 × 10−1 rs5014418 1.116 × 10−2 2.738 × 10−13
rs2853934 8.336 × 10−2 rs9276448 8.878 × 10−3 2.507 × 10−13
rs2524115 1.215 × 10−1 rs9276448 8.878 × 10−3 6.456 × 10−13
rs3873385 3.368 × 10−1 rs9276448 8.878 × 10−3 3.186 × 10−14
rs3873385 3.368 × 10−1 rs5014418 1.116 × 10−2 3.841 × 10−14
rs3873385 3.368 × 10−1 rs6919798 6.077 × 10−2 4.257 × 10−13
rs396038 9.939 × 10−2 rs9276448 8.878 × 10−3 5.894 × 10−13
Table 2: The interaction SNP pairs in the two regions shown in Figure
2. The SNPs in the column ‘SNP 1’ reside in the gene HLA-B and
The SNPs in the column ‘SNP 2’ locate at the block across the genes
HLA-DQA2 and HLA-DQB2. They show strong interactions without
displaying significant main effects.
selected 89,294 SNPs genotyped in 5000 samples. It is unknown
how much time Random Jungle will need to find interactions from
360, 000 SNPs. However, Random Jungle aims at detecting associ-
ation allowing for interactions rather than detecting interactions (see
detailed explanations in the supplementary). Besides, Random Jun-
gle has the difficulty of finding interacting SNP pairs displaying weak
main effects because trees built in Random Jungle are conditional on
the main effects of SNPs. BEAM took about 8 days to handle 47,727
SNPs using 5× 107 Markov chain Monte Carlo iterations. Currently,
BEAM fails to handle 500, 000 to 1, 000, 000 SNPs genotyped in
5000 or more samples. Cordell [5] recommended PLINK and Ran-
dom Jungle as two most computationally feasible methods.
Our method BOOST makes a tremendous progress. It evaluated all
pairs of roughly 360, 000 SNPs within 60 hours (around 2.5 days) on
a standard desktop (3.0 GHz CPU with 4G memory running Windows
XP professional x64 Edition system). The WTCCC phase 2 study
will analyze over 60,000 samples of various diseases using either the
Affymetrix v6.0 chip or the Illumina 660K chip. The shared control
samples will increase from 3, 000 to 6, 000. Such an increase in num-
bers of SNPs and sample size are more demanding on the computation
efficiency. We anticipate that BOOST is still applicable to analyze the
new data sets.
CONCLUSION
The large number of SNPs genotyped in genome-wide case-control
studies poses a great computational challenge in identification of
gene-gene interactions. During the last few years, there have been fast
growing interests in developing and applying computational and sta-
tistical approaches to finding gene-gene interactions. However, many
approaches fail to handle genome-wide data sets (e.g., 500, 000 SNPs
and 5, 000 samples). This hampers identification of interactions in
genome-wide case-control studies. In this paper, we present a method
named ‘BOOST’ to address this problem. We have successfully ap-
plied our method to analyze seven data sets from WTCCC. Not only
is BOOST computationally efficient, it also has the advantage over
PLINK with respect to the statistical power (see simulation study in
the supplementary). Our experiment results demonstrate that inter-
action mapping is both computationally and statistically feasible for
hundreds of thousands of SNPs genotyped in thousands of samples.
METHODS
Boolean representation of genotype data. Suppose we haveL SNPs
and n samples. The data set is usually stored in an L × n matrix.
Each cell in this matrix takes a value in {1, 2, 3}, which represent ho-
mozygous reference genotype, heterozygous genotype and homozy-
gous variant genotype, respectively. In our method, we introduce a
Boolean representation of genotype data (the details are provided in
the supplementary). This Boolean representation promotes not only
the space efficiency but also the CPU efficiency because it only in-
volves Boolean values and thus allows using fast logic (bitwise) oper-
ations to obtain contingency tables.
Measuring interaction effects. Logistic regression models are of-
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Figure 1: Top-left panel: Single-locus association mapping of T1D and RA. They share a very similar hit region in chromosome 6. Top-
right panel: The LD map of the MHC region in control samples. Bottom panel: Genome-wide interaction mapping of T1D and RA. 99.8%
interactions of T1D and 80.0% interactions of RA are in the MHC region. Strong interaction effects widely exist between genes in and across
the MHC class I, II and III in T1D, while most significant interactions of RA only involve loci closely placed in the MHC class II region (The
P values are truncated at P = 1.0× 10−16).
(a) (b)
Figure 2: Interactions between the genes in the MHC class I and those in the MHC class II. Left panel (a): The region 31350k - 31390k
of Chromosome 6. The gene HLA-B in the MHC class I locates in this region. The recombination rate and LD plot from HapMap show
that a block structure spans from 31360k to 31380k. This region is mapped through the SNPs rs2524057, rs2853934, rs2524115, rs396038,
rs3873385, rs2524095, and rs2524089. The SNPs rs2524095 and rs2524089 are involved in the interactions with the region 32930k - 32960k
shown in Figure 1(b) of the supplementary. Right panel (b): The region 32810k - 32860k of Chromosome 6. The genes HLA-DQA2 and
HLA-DQB2 in the MHC class II reside in this region. The recombination rate and LD plot from HapMap show that a block structure exists
from 32820k to 32847k. This region is mapped through the genotyped SNPs rs9276448, rs5014418, and rs6919798. The ungenotyped SNPs
rs9276438 and rs7774954 reside in the genes HLA-DQA2 and HLA-DQB2, respectively. They are in strong LD with those genotyped SNPs.
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ten used to measure the strength of gene-gene interactions [4, 5]. Let
LM and LF be the log likelihood of the logistic regression model
MM with only main effect terms (df = 4) and the full model MF
with both main effect terms and interaction terms (df = 8), respec-
tively. An interaction effect is measured by the difference of the log
likelihood evaluated at maximum likelihood estimation (MLE), i.e.,
LˆF − LˆM . The likelihood ratio statistic 2(LˆF − LˆM ) is asymptot-
ically χ2 distributed with df = 4. However, it is computationally
unaffordable to directly use this measure to evaluate all pairs of SNPs
in a genome-wide case-control study because there are hundreds of
billions of pairs to be tested.
Noticing the correspondence between a logistic regression model
and a log-linear model in categorical data analysis [1], we are able to
measure an interaction effect under log-linear models. In the space
of log-linear models, the homogenous model MH is the equivalent
form of the main effect model MM and the saturated model MS is
the equivalent form of the full model MF . Let LˆH and LˆS be the
log-likelihood of MH and MS evaluated at their MLEs, respectively.
Interaction effects can thus be measured using LˆS − LˆH . After some
algebra, it turns out that LˆS − LˆH is connected with the Kullback-
Leibler divergence [6]:
LˆS − LˆH = n ·DKL(pˆi||pˆ), (1)
where n is the number of samples, pˆi is the joint distribution estimated
under MS and pˆ is the joint distribution estimated under MH . More
details can be found in the supplementary.
Boolean operation based screening and testing. In Eq.(1), there
is no closed-form solution for pˆ under the model MH . Using iter-
ative methods to estimate pˆ is computationally intensive to test all
SNP pairs in genome-wide case-control studies. Here we use a non-
iterative method known as ‘Kirkwood Superposition Approximation’
(KSA) [11] to approximate pˆ, denoted as pˆK . Let LˆKSA be the log-
likelihood of KSA model evaluated at its MLE. We show that
LˆS − LˆH ≤ LˆS − LˆKSA. (2)
In other words, LˆS − LˆKSA = n ·DKL(pˆi||pˆK) is an upper bound
of LˆS − LˆH (please check the supplementary for details). Based on
this upper bound, we propose our new method ‘BOolean Operation
based Screening and Testing’ (BOOST):
• Stage 1 (Screening): we evaluate all pairwise interactions by
using KSA in the screening stage. For each pair, the calcu-
lation of 2(LˆS − LˆKSA) = 2n · DKL(pˆi||pˆK) is based on
the contingency table collected by using Boolean operations.
Since 2(LˆS − LˆH) ≤ 2(LˆS − LˆKSA), an interaction ob-
tained by KSA without passing a specified threshold τ , i.e.,
2(LˆS − LˆKSA) ≤ τ , would not be considered in Stage 2. We
set the threshold τ = 30 in our experiment.6
• Stage 2 (Testing): For each pair with 2(LˆS − LˆKSA) > τ ,
we test the interaction effect using the likelihood ratio statistic
2(LˆS − LˆH). We fit the log-linear models MH and MS , and
calculate this test statistic using Eq. (1). After that, we conduct
the χ2 test with df = 4 to determine whether the interaction
effect is significant.
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